Get the Stockscreener App
35.88
2.78%
0.97
After Hours:
35.88
Astrana Health Inc stock is traded at $35.88, with a volume of 310.36K.
It is up +2.78% in the last 24 hours and down -6.97% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$34.91
Open:
$35.53
24h Volume:
310.36K
Relative Volume:
0.61
Market Cap:
$1.78B
Revenue:
$3.53B
Net Income/Loss:
$30.99M
P/E Ratio:
58.49
EPS:
0.6134
Net Cash Flow:
$154.99M
1W Performance:
-1.35%
1M Performance:
-6.97%
6M Performance:
+43.23%
1Y Performance:
+29.20%
1-Day Range:
$35.11
$36.39
1-Week Range:
$34.46
$36.83
52-Week Range:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
35.88 | 1.80B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
426.69 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
258.62 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.25 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
119.80 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
178.69 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Investigation launched into Astrana Health over alleged securities fraud after stock drops 9%. - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH - PR Newswire
Freedom Capital Markets maintains Buy rating on Astrana Health, $50 price target - TradingView
Astrana Health Inc. (ASTH) Stock Forecasts - Yahoo Finance
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Astrana Health, Inc - The National Law Review
Astrana Health Hack: SEC Filing Lands Sept. 22 [2026] - shattered.io
Astrana Health Inc. Earnings and Revenue – HAN:3AM - TradingView
Revenue per share of Astrana Health Inc. – HAN:3AM - TradingView
Astrana Health Inc. Statistics – HAN:3AM - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - GlobeNewswire Inc.
Astrana Health Inc. (ASTH) Slips 3.41% to $35.13 as Shares Test Lower SupportRatio Spread Trade - siam.in
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law - Business Wire
Astrana Health Reveals Spoofing Attack Targeting Private Data - Law360
Astrana Health Inc (ASTH) Stock Up 5.6% and Still Undervalued -- GF Score: 88/100 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Health, Inc. (ASTH) And Encourages Investors to Connect - accessnewswire.com
Astrana Health faces securities fraud probe aft... - Pluang
Apollo Medical Holdings Inc (3AM.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Health, Inc. (ASTH) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Healt - The National Law Review
Astrana buys Prospect's managed care arm for $708M out of bankruptcy - Dealroom
Astrana Health, Inc. (ASTH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Astrana Health, Inc. (ASTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why Astrana Health (ASTH) Shares Are Trading Lower Today - Yahoo Finance
Astrana Health Q3 Results: Sales guide $1.000B-$1.030B vs $1.021B est - scanx.trade
Astrana Health Latest Results: Sales guidance affirmed at $3.8B-$4.1B - scanx.trade
Astrana Health FY26 Results: Sales guidance affirmed at $3.800B-$4.100B - scanx.trade
Astrana Health, Inc. - reuters.com
Astrana Health Reports Material Cyberattack; Shares Fall Pre-Bell - marketscreener.com
Astrana is latest U.S. healthcare company to face acyberattack - TradingView
Material cyber incident at Astrana Health (NASDAQ: ASTH); data review underway - Stock Titan
Astrana Health (ASTH) Stock May Be Fully Priced As Shares Fell 67% - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Astrana Health, Inc. (ASTH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Lowey Dannenberg, P.C. is Investigating Astrana Health, - GlobeNewswire
Astrana Health Inc. (ASTH) Stock Analysis: A Promising 54% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Lowey Dannenberg probes Astrana Health after short-seller report - scanx.trade
M&A AwardsDEAL OF THE YEAR$500 MILLION – $1 BILLION HONOREE: Astrana Health acquires Prospect Medical Holdings - Los Angeles Business Journal
Astrana Health: Strong Execution, Still No Re-Rating (NASDAQ:ASTH) - Seeking Alpha
A Look at Astrana Health Inc (ASTH) After 9.0% Decline -- GF Val - GuruFocus
Astrana Health stock tumbles after short report - Investing.com
Astrana Health stock tumbles after short report By Investing.com - Investing.com Canada
Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report - Moomoo
Astrana Health falls amid short call from GlassHouse Research - TradingView
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance
Form 8K Astrana Health Inc For: 15 September By Investing.com - Investing.com India
Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint - TradingView
Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53 - Moomoo
Oppenheimer Initiates Astrana Health at Outperform With $53 Price Target - marketscreener.com
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down - The Globe and Mail
ETFs Investing in Astrana Health Inc. Stocks - TradingView
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sim Brandon | CEO and President |
Feb 02 '26 |
Option Exercise |
23.24 |
21,334 |
495,802 |
1,045,329 |
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):